TAK
Showing 26 - 50 of 915
Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Unresectable Locally Advanced or Metastatic Cancer Trial in Clayton (TAK-280)
Recruiting
- Unresectable Locally Advanced or Metastatic Cancer
-
Clayton, AustraliaMonash Medical Centre
May 5, 2022
Postoperative Nausea and Vomiting (PONV) Trial in United States (TAK-951, Ondansetron, Ondansetron Placebo)
Completed
- Postoperative Nausea and Vomiting (PONV)
- TAK-951
- +3 more
-
Sheffield, Alabama
- +6 more
Jul 21, 2022
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)
Recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)
-
Nagoya, Aichi, Japan
- +16 more
Feb 2, 2023
Solid Tumors Trial in Kashiwa, Nishinomiya, Chuo-ku (TAK-103)
Recruiting
- Solid Tumors
- TAK-103
-
Kashiwa, Chiba, Japan
- +2 more
Mar 10, 2022
Coronavirus Disease (COVID-19) Trial in Sumida-ku, Fukuoka (TAK-919, Placebo)
Completed
- Coronavirus Disease (COVID-19)
- TAK-919
- Placebo
-
Sumida-ku, Tokyo, Japan
- +1 more
Mar 4, 2022
COVID-19 Pandemic Trial in Mae Sot (STANDARD Q COVID-19 Ag Test)
Active, not recruiting
- COVID-19 Pandemic
- STANDARD Q COVID-19 Ag Test
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit
Dec 5, 2022
Healthy Volunteers Trial in Hialeah (TAK-881)
Completed
- Healthy Volunteers
- TAK-881
-
Hialeah, FloridaClinical Pharmacology of Miami
Apr 28, 2022
Von Willebrand Disease (VWD) Trial (Recombinant von Willebrand Factor (rVWF), ADVATE)
Not yet recruiting
- Von Willebrand Disease (VWD)
- Recombinant von Willebrand Factor (rVWF)
- ADVATE
- (no location specified)
Oct 14, 2022
Sleep Apnea Trial in Adelaide (Danavorexton, Placebo)
Recruiting
- Sleep Apnea
- Danavorexton
- Placebo
-
Adelaide, AustraliaAdelaide Institute for Sleep Health (AISH), Flinders University
May 11, 2022
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Trial in Sumida-ku,
Completed
- Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
- TAK-019
- Placebo
-
Sumida-ku, Tokyo, Japan
- +1 more
Apr 6, 2022
Squamous Cell Cancer of Head and Neck (SCCHN), NSCLC (NSCLC), Colorectal Cancer Trial in Australia (MVC-101 (TAK-186))
Recruiting
- Squamous Cell Cancer of Head and Neck (SCCHN)
- +2 more
- MVC-101 (TAK-186)
-
Randwick, New South Wales, Australia
- +3 more
Sep 14, 2022
Healthy Volunteers Trial in Tempe (Maribavir Commercial Tablet Formulation, Maribavir Pediatric Powder-for-oral Suspension
Not yet recruiting
- Healthy Volunteers
- Maribavir Commercial Tablet Formulation
- +2 more
-
Tempe, ArizonaCelerion
Jun 16, 2023
Congenital Protein C Deficiency Trial in Kashihara, Chiba, Saitama (TAK-662)
Active, not recruiting
- Congenital Protein C Deficiency
-
Kashihara, Nara, Japan
- +3 more
Apr 7, 2022
Healthy Volunteers Trial in Lincoln (TAK-935 Oral Tablet, [14C]TAK-935 IV Infusion, [14C]TAK-935 Oral Solution)
Completed
- Healthy Volunteers
- TAK-935 Oral Tablet
- +2 more
-
Lincoln, NebraskaCelerion
Oct 1, 2021
Acquired Hemophilia A Trial in Japan (TAK-672)
Recruiting
- Acquired Hemophilia A
- TAK-672
-
Maebashi, Gunma, Japan
- +8 more
Jan 13, 2022